Ellen Feigal - 01 Oct 2021 Form 4 Insider Report for NextCure, Inc. (NXTC)

Role
Director
Signature
/s/ Steven P. Cobourn, as attorney-in-fact for Ellen Feigal
Issuer symbol
NXTC
Transactions as of
01 Oct 2021
Net transactions value
$0
Form type
4
Filing time
05 Oct 2021, 16:08:59 UTC
Previous filing
25 Jun 2021
Next filing
27 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXTC Stock Option (Right to Buy) Award $0 +28,500 $0.000000 28,500 01 Oct 2021 Common Stock 28,500 $7.56 Direct F1
transaction NXTC Stock Option (Right to Buy) Award $0 +10,384 $0.000000 10,384 01 Oct 2021 Common Stock 10,384 $7.56 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in three equal annual installments beginning on October 1, 2021.
F2 The option vests in full on the earlier of June 24, 2022 and the date of the 2022 Annual Meeting of Stockholders.